T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides

The fate of in vivo activated CD8+ cytotoxic T cells was studied in transgenic mice expressing a T cell receptor (TCR) specific for the lymphocytic choriomeningitis virus (LCMV) glycoprotein peptide 33‐41 presented by major histocompatibility complex (MHC) class I molecules. LCMV infection of TCR transgenic mice induced LCMV‐specific effector and memory T cells whereas injection of soluble LCMV glycoprotein peptide 33‐41 resulted in tolerance by peripheral deletion and anergy of LCMV‐specific T cells after an initial expansion phase. Similarly, LCMV peptide 33‐41‐specific tolerance could be achieved in normal C57BL/6 mice and was not abrogated by an LCMV infection. These results obtained with a classically MHC‐restricted peptide antigen parallel previous findings with retroviral or bacterial superantigens and indicate a possibility to modulate specifically mature peripheral cytotoxic T lymphocytes in vivo.

[1]  A. Monaco,et al.  STUDIES ON HETEROLOGOUS ANTI‐LYMPHOCYTE SERUM IN MICE. III. IMMUNOLOGIC TOLERANCE AND CHIMERISM PRODUCED ACROSS THE H‐2 LOCUS WITH ADULT THYMECTOMY AND ANTI‐LYMPHOCYTE SERUM * , 1966, The Journal of Immunology.

[2]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[3]  R. Zinkernagel,et al.  Major histocompatibility complex – dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease , 1989, European journal of immunology.

[4]  H. Pircher,et al.  Preferential positive selection of Vα2+CD8+ T cells in mouse strains expressing both H‐2k and T cell receptor Vαa haplotypes: determination with a Vα2‐specific monoclonal antibody , 1992, European journal of immunology.

[5]  Rolf M. Zinkernagel,et al.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.

[6]  H. Pircher,et al.  Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen , 1989, Nature.

[7]  R. Zinkernagel,et al.  T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens , 1988, Nature.

[8]  J. Whitton,et al.  Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus , 1988, Journal of virology.

[9]  P. Marrack,et al.  Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex , 1988, Nature.

[10]  Rolf M. Zinkernagel,et al.  Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo , 1990, Nature.

[11]  W. Fung-Leung,et al.  Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. , 1992, Journal of immunology.

[12]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[13]  P. Marrack,et al.  Identification of the region of T cell receptor β chain that interacts with the self-superantigen MIs-1a , 1990, Cell.

[14]  R. Miller,et al.  Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells. , 1992, International immunology.

[15]  H. Boehmer,et al.  Developmental biology of T cells in T cell-receptor transgenic mice. , 1990 .

[16]  P. Romero,et al.  Differential stability of antigenic MHC class I-restricted synthetic peptides. , 1991, Journal of immunology.

[17]  Y. Kawabe,et al.  Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice , 1990, The Journal of experimental medicine.

[18]  J. Sprent,et al.  T Cell Selection in the Thymus , 1988, Immunological reviews.

[19]  H. Rammensee,et al.  In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine , 1989, Nature.

[20]  W. Kast,et al.  Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Zinkernagel,et al.  Peptide-induced antiviral protection by cytotoxic T cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Pircher,et al.  Characterization of virus‐specific cytotoxic T cell clones from allogeneic bone marrow chimeras , 1987, European journal of immunology.

[23]  K. Lafferty,et al.  A new analysis of allogeneic interactions. , 1975, The Australian journal of experimental biology and medical science.

[24]  B. Rellahan,et al.  In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B , 1990, The Journal of experimental medicine.

[25]  Lawrence Steinman,et al.  Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy , 1989, Cell.

[26]  H. Rammensee,et al.  Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells , 1989, Nature.

[27]  R. Zinkernagel,et al.  Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide , 1990, The Journal of experimental medicine.

[28]  L. Hood,et al.  Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein , 1989, The Journal of experimental medicine.

[29]  J. Whitton,et al.  Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. , 1988, Virology.

[30]  B. Rocha,et al.  Peripheral selection of the T cell repertoire. , 1991, Science.

[31]  P. Marrack,et al.  A T cell receptor Vβ segment that imparts reactivity to a class II major histocompatibility complex product , 1987, Cell.

[32]  J. Berzofsky,et al.  Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs , 1990, Nature.

[33]  H. Mcdevitt,et al.  A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Whitton,et al.  Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes , 1988, The Journal of experimental medicine.

[35]  J. Sprent,et al.  Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity , 1990, Cell.

[36]  B. Malissen,et al.  Interaction of antigenic peptides with MHC class I molecules on living cells studied by photoaffinity labeling. , 1992, Journal of immunology.

[37]  C. Janeway,et al.  T‐Cell Responses to Mls and to Bacterial Proteins that Mimic its Behavior # , 1989, Immunological reviews.

[38]  A. Gaur,et al.  Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. , 1992, Science.

[39]  C. Mims,et al.  Immunofluorescence study of the mechanism of resistance to superinfection in mice carrying the lymphocytic choriomeningitis virus. , 1966, The Journal of pathology and bacteriology.

[40]  D. Kioussis,et al.  Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Benoist,et al.  Superantigens interact with MHC class II molecules outside of the antigen groove , 1990, Cell.

[42]  E. Unanue,et al.  Regulation of macrophage populations. I. Preferential induction of Ia-rich peritoneal exudates by immunologic stimuli. , 1980, Journal of immunology.

[43]  M. Gefter,et al.  Immunological activity of covalently linked T-cell epitopes , 1990, Nature.

[44]  Philippa Marrack,et al.  The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice , 1989, Cell.